Pacer Advisors’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-7,078
| Closed | -$175K | – | 3807 |
|
|
2025
Q3 | $175K | Buy |
+7,078
| New | +$158K | ﹤0.01% | 2000 |
|
|
2025
Q1 | – | Sell |
-13,847
| Closed | -$549K | – | 3633 |
|
|
2024
Q4 | $549K | Buy |
13,847
+325
| +2% | +$14.7K | ﹤0.01% | 1588 |
|
|
2024
Q3 | $857K | Sell |
13,522
-361
| -3% | -$26.1K | ﹤0.01% | 1447 |
|
|
2024
Q2 | $938K | Buy |
13,883
+3
| +0% | +$209 | ﹤0.01% | 1348 |
|
|
2024
Q1 | $1.1M | Buy |
13,880
+21
| +0.2% | +$1.72K | ﹤0.01% | 1174 |
|
|
2023
Q4 | $1.08M | Buy |
13,859
+6,157
| +80% | +$456K | ﹤0.01% | 1104 |
|
|
2023
Q3 | $542K | Sell |
7,702
-8,398
| -52% | -$627K | ﹤0.01% | 1090 |
|
|
2023
Q2 | $1.28M | Buy |
+16,100
| New | +$1.16M | 0.01% | 939 |
|
|
2023
Q1 | – | Sell |
-17,434
| Closed | -$1.44M | – | 2189 |
|
|
2022
Q4 | $1.44M | Buy |
+17,434
| New | +$1.44M | 0.01% | 662 |
|
|
2022
Q1 | – | Sell |
-15,852
| Closed | -$962K | – | 2266 |
|
|
2021
Q4 | $962K | Buy |
15,852
+195
| +1% | +$11.6K | 0.01% | 1228 |
|
|
2021
Q3 | $999K | Sell |
15,657
-20,865
| -57% | -$1.32M | 0.01% | 876 |
|
|
2021
Q2 | $2.29M | Buy |
36,522
+27,027
| +285% | +$1.69M | 0.03% | 583 |
|
|
2021
Q1 | $543K | Sell |
9,495
-418
| -4% | -$22.6K | 0.01% | 1019 |
|
|
2020
Q4 | $498K | Sell |
9,913
-11,541
| -54% | -$460K | 0.01% | 975 |
|
|
2020
Q3 | $632K | Buy |
+21,454
| New | +$623K | 0.01% | 905 |
|
|
2020
Q1 | – | Sell |
-30,379
| Closed | -$1.01M | – | 662 |
|
|
2019
Q4 | $1.01M | Sell |
30,379
-2,301
| -7% | -$72.1K | 0.05% | 541 |
|
|
2019
Q3 | $1.02M | Sell |
32,680
-2,516
| -7% | -$76.6K | 0.02% | 820 |
|
|
2019
Q2 | $1.23M | Buy |
+35,196
| New | +$1.14M | 0.03% | 732 |
|
|
2019
Q1 | – | Sell |
-749
| Closed | -$19K | – | 743 |
|
|
2018
Q4 | $19K | Sell |
749
-31,845
| -98% | -$1.1M | ﹤0.01% | 397 |
|
|
2018
Q3 | $1.15M | Buy |
32,594
+6,634
| +26% | +$264K | 0.04% | 596 |
|
|
2018
Q2 | $1.06M | Buy |
25,960
+3,890
| +18% | +$157K | 0.05% | 592 |
|
|
2018
Q1 | $865K | Buy |
22,070
+2,332
| +12% | +$85.5K | 0.05% | 536 |
|
|
2017
Q4 | $644K | Buy |
19,738
+9,636
| +95% | +$334K | 0.05% | 615 |
|
|
2017
Q3 | $482K | Sell |
10,102
-263
| -3% | -$12.8K | 0.04% | 697 |
|
|
2017
Q2 | $512K | Buy |
10,365
+226
| +2% | +$10K | 0.05% | 591 |
|
|
2017
Q1 | $442K | Buy |
10,139
+250
| +3% | +$10.1K | 0.05% | 555 |
|
|
2016
Q4 | $328K | Buy |
9,889
+186
| +2% | +$7.22K | 0.05% | 636 |
|
|
2016
Q3 | $481K | Buy |
9,703
+826
| +9% | +$43K | 0.07% | 380 |
|
|
2016
Q2 | $491K | Buy |
8,877
+7,328
| +473% | +$429K | 0.08% | 336 |
|
|
2016
Q1 | $85K | Buy |
+1,549
| New | +$88.4K | 0.02% | 654 |
|
Other funds holding ACHC
KCM
DM
ABI
DCM
JFG
Pacer Advisors's ACHC Position: Q4 2025 in Review
Pacer Advisors sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 7,078 shares — an estimated $175K sold.
Pacer Advisors first reported a position in ACHC in Q1 2016 and held it in 30 quarters. The position peaked at $2.29M in Q2 2021. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.
- Pacer Advisors reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
- Pacer Advisors sold 7,078 Acadia Healthcare shares in Q4 2025, an estimated $175K.
- Pacer Advisors first reported a position in Acadia Healthcare in Q1 2016 and held it in 30 quarters.
- Pacer Advisors's Acadia Healthcare position peaked at $2.29M in Q2 2021.
- 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.
Based on Pacer Advisors's 13F filing for Q4 2025, filed 4 Feb 2026.